68.41 F
New York
August 1, 2021


Biogen’s controversial Alzheimer’s drug generates $2 million in first few weeks after approval

CNBC – For more and to sign up click here Aduhelm by Biogen Source: Biogen Biogen‘s Alzheimer’s drug, Adhulem, generated $2 million in revenue in the first few weeks of its approval, the company said Thursday in releasing its second-quarter earnings along with an open letter about the controversial drug.......

Moderna says Covid booster shot generates promising immune response against variants found in South Africa, Brazil

CNBC – For more and to sign up click here A doctor draws up a syringe with Moderna’s vaccine. Oliver Berg | picture alliance | Getty Images A booster shot of Moderna‘s Covid-19 vaccine generated a promising immune response against the B.1.351 and P.1 variants first identified in South Africa......

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Click whichever is suitable. Accept Read More